Administration of Bifidobacterium animalis subsp. lactis strain BB-12® in healthy children: characterization, functional composition, and metabolism of the gut microbiome

Frontiers in Microbiology

Microbiology

Tina P. Tan¹  Daniel J. Merenstein¹  Carlotta Vizioli²  Alexis Franks³  Brianna Brooks³  Paule V. Joseph⁴  Rosario Jaime-Lara⁵  Kyle Bittinger⁶  Scott G. Daniel⁶  Ana F. Diallo⁷  Katherine A. Maki⁸ 

[1] Department of Family Medicine, Georgetown University Medical Center, Washington, DC, United States;Department of Health and Human Services, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States;Department of Health and Human Services, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, United States;UCLA School of Nursing, University of California, Los Angeles, Los Angeles, CA, United States;Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA, United States;Family and Community Health Nursing, School of Nursing, Institute of Inclusion, Inquiry and Innovation (iCubed), Virginia Commonwealth University, Richmond, VA, United States;Translational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, Bethesda, MD, United States;

关键词: probiotics;    gut microbiome;    L. delbrueckii;    B. animalis;    metagenomics;    S. thermophilus;    children;    metabolomics;   

DOI  :  10.3389/fmicb.2023.1165771

 received in 2023-02-14, accepted in 2023-04-17,  发布年份 2023

来源: Frontiers

【 摘 要 】

IntroductionThe consumption of probiotics may influence children’s gut microbiome and metabolome, which may reflect shifts in gut microbial diversity composition and metabolism. These potential changes might have a beneficial impact on health. However, there is a lack of evidence investigating the effect of probiotics on the gut microbiome and metabolome of children. We aimed to examine the potential impact of a two (Streptococcus thermophilus and Lactobacillus delbrueckii; S2) vs. three (S2 + Bifidobacterium animalis subsp. lactis strain BB-12) strain-supplemented yogurt.MethodsIncluded in this study were 59 participants, aged one to five years old, recruited to phase I of a double-blinded, randomized controlled trial. Fecal samples were collected at baseline, after the intervention, and at twenty days post-intervention discontinuation, and untargeted metabolomics and shotgun metagenomics were performed.ResultsShotgun metagenomics and metabolomic analyses showed no global changes in either intervention group’s gut microbiome alpha or beta diversity indices, except for a lower microbial diversity in the S2 + BB12 group at Day 30. The relative abundance of the two and three intervention bacteria increased in the S2 and S2 + BB12 groups, respectively, from Day 0 to Day 10. In the S2 + BB12 group, the abundance of several fecal metabolites increased at Day 10, including alanine, glycine, lysine, phenylalanine, serine, and valine. These fecal metabolite changes did not occur in the S2 group.DiscussionIn conclusion, there were were no significant differences in the global metagenomic or metabolomic profiles between healthy children receiving two (S2) vs. three (S2 + BB12) probiotic strains for 10 days. Nevertheless, we observed asignificant increase (Day 0 to Day 10) in the relative abundance of the two and three probiotics administered in the S2 and S2 + BB12 groups, respectively, indicating the intervention had a measurable impact on the bacteria of interest in the gut microbiome.Future research using longer probiotic intervention durations and in children at risk for gastrointestinal disorders may elucidate if functional metabolite changes confer a protective gastrointestinal effect.

【 授权许可】

Unknown   
Copyright © 2023 Vizioli, Jaime-Lara, Daniel, Franks, Diallo, Bittinger, Tan, Merenstein, Brooks, Joseph and Maki.